Professor Nick Turner on palbociclib extending breast cancer survival

Professor Nick Turner discusses the latest results from a phase III clinical trial (Paloma-3) of the drug the findings strengthen the case for making palbociclib available to women whose cancer has progressed on prior hormone therapy.


Leave a Reply

Your email address will not be published. Required fields are marked *